Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Horizon Therapeutics
Pharma
Amid buzz for Amgen's obesity drug, company sees revenue boost
The buzz about Amgen’s obesity pipeline overshadowed the company’s solid work on the top line as revenue came in at $7.4 billion for a 22% increase.
Kevin Dunleavy
May 3, 2024 9:05am
Amgen reports 3rd straight sequential sales increase for Tepezza
Feb 7, 2024 10:03am
Amgen swings into golf sponsorship, rebadging ex-Horizon deals
Dec 18, 2023 8:05am
Amgen lays out plan to boost sales of newly acquired Tepezza
Oct 31, 2023 11:29am
Amgen will ax 350 former Horizon workers after $28B buyout
Oct 24, 2023 2:41pm
Pharma's reputation among neurology patient groups rises again
Oct 17, 2023 10:50am